Business / Finance

RSS

Jefferson, RMA of Philadelphia announce clinical partnership

Jefferson announced today its clinical partnership with RMA of Philadelphia, merging the expertise of two outstanding groups of reproductive specialists on its Center City campus.

11 Feb 2015

Psychemedics' revenue increases 4% to $6.8 million in fourth quarter 2014

Psychemedics Corporation today announced fourth quarter and year-end financial results for the period ended December 31, 2014. The Company also announced a quarterly dividend of $0.15 per share payable to shareholders of record as of February 23, 2015 to be paid on March 6, 2015. This will be the Company's 74th consecutive quarterly dividend.

11 Feb 2015

UM one step closer to developing potential drug for treating brain cancer

Promentis Pharmaceuticals, Inc. recently announced it will enter an exclusive agreement with UM to commercialize a discovery made by a team of UM faculty scientists that has the potential to treat brain cancer and possibly other disorders of the central nervous system.

11 Feb 2015

Kaiser denies Prime Healthcare claims over purchase of Daughters of Charity Health System

In a bizarre announcement, Prime Healthcare said Monday that Kaiser Permanente was now supporting its purchase of Daughters of Charity Health System, a claim that Kaiser has unequivocally denied.

11 Feb 2015

DePuy Synthes announces acquisition of Olive Medical

Today DePuy Synthes Companies announced that it has acquired Olive Medical Corporation, a Utah-based privately held provider of high definition (HD) visualization systems for minimally invasive surgery (MIS). Financial terms of the transaction were not disclosed.

10 Feb 2015

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Pfenex Inc., a clinical-stage biotechnology company engaged in the development of biosimilar therapeutics, and Hospira, Inc., the world's leading provider of injectable drugs and infusion technologies, and a global leader in biosimilars, today announced that the companies have entered into an agreement to exclusively develop and commercialize for worldwide sales PF582, Pfenex's biosimilar candidate to Genentech's LUCENTIS (ranibizumab injection).

10 Feb 2015

Bayer materials withstand demanding conditions and meet requirements for innovative medical devices MD&M West

Increasingly, innovative medical applications place further importance on the success of the materials they use. When patients’ health, mobility and comfort are involved, reliability and durability are crucial. Bayer MaterialScience LLC steps up to the challenge offering original equipment manufacturers (OEMs) a wide range of material solutions for their medical application needs.

10 Feb 2015

Isis receives $5 million from Biogen Idec to develop drugs for neurological disorders

Isis Pharmaceuticals, Inc. announced today it has earned a $5 million milestone payment from Biogen Idec associated with the validation of an undisclosed target to treat a neurological disorder under its broad strategic collaboration with Biogen Idec to develop drugs to treat patients with neurological disorders.

10 Feb 2015

PBI announces receipt of first purchase order for new Barozyme HT48 High-throughput System

Pressure BioSciences, Inc., a leader in the development and sale of broadly enabling sample preparation solutions using pressure cycling technology ("PCT")-based instruments and consumables to the worldwide life sciences industry, today announced the receipt of the first purchase order for its new Barozyme HT48 High-throughput System.

10 Feb 2015

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Quest Diagnostics, the world's leading provider of diagnostic information services, today announced that it and Myriad Genetics Inc. have reached an agreement that ends their BRCA gene-patent litigation.

From Quest Diagnostics 10 Feb 2015

Roche announces acquisition of Signature Diagnostics

Roche announced today the acquisition of Signature Diagnostics AG, a privately held company based in Potsdam, Germany. Signature is a translational oncology and genomics company that develops large blood plasma and tissue biobanks in multiple cancers, including colorectal and lung, which are constructed from multicenter prospective clinical studies.

From Roche Sequencing and Life Science 10 Feb 2015

Blyth's Silver Star Brands business unit acquires Native Remedies assets

Blyth, Inc., a direct-to-consumer company and leading designer and marketer of candles and accessories for the home and health, wellness and beauty products, household convenience items and personalized gifts sold through the direct selling and direct marketing channels, announced that its Silver Star Brands business unit has acquired certain of the assets of Native Remedies LLC.

9 Feb 2015

Xenics and VUmc collaborate in thermography project for clinical research

Xenics, Europe's leading developer and manufacturer of advanced infrared imagers, cameras and customized imaging solutions from the LWIR to the visible realm, is collaborating in path breaking clinical research programs with the VU University Medical Center of Amsterdam, The Netherlands.

9 Feb 2015

Gilead Sciences, Mobiquity make significant healthcare investment in London

London's status as a leading centre for the life sciences, financial and digital industries has attracted significant new investment by two leading US companies, announced today as Mayor of London Boris Johnson visited Boston as part of a trade delegation to the East Coast of the USA.

9 Feb 2015

Lintec to commercialize carbon nanotubes developed at UTD

Lintec of America recently announced an exclusive license to commercialize novel fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, yarns and ribbons, developed at the University of Texas at Dallas.

9 Feb 2015

Trovagene to sell underwritten public offering of common stock

Trovagene, Inc., a developer of cell-free molecular diagnostics, today announced that it is offering to sell shares of its common stock in an underwritten public offering. The offering is expected to price on or about Friday, February 6, 2015.

6 Feb 2015

Marken launches new marketing campaign to solidify its place as industry's only Clinical Logistics Organization

Marken is starting its 35th year as a specialist logistics company and has launched a new marketing campaign to solidify its place as the industry's only Clinical Logistics Organization (CLO).

6 Feb 2015

Asterias Biotherapeutics prices underwritten public offering of common stock at $3.90 per share

Asterias Biotherapeutics, Inc., a leading biotechnology company in the emerging field of regenerative medicine, today announced today that it has priced an underwritten public offering of its common stock at a price of $3.90 per share.

6 Feb 2015

G1 Therapeutics receives $33 million in Series B funding to develop effective treatments for cancer

An RTP-based pharmaceutical company with roots at the University of North Carolina at Chapel Hill has received $33 million in Series B venture capital funding to develop more effective and less toxic methods to treat patients with cancer.

6 Feb 2015

Alexian Brothers Health System acquires primary care medical group in suburban Chicago

Alexian Brothers Health System, a member of Ascension, the nation's largest Catholic and non-profit health system, is expanding its network of primary care physicians with the acquisition of a long-standing primary care medical group in suburban Chicago.

6 Feb 2015

Business / Finance

Jefferson, RMA of Philadelphia announce clinical partnership

Psychemedics' revenue increases 4% to $6.8 million in fourth quarter 2014

UM one step closer to developing potential drug for treating brain cancer

Kaiser denies Prime Healthcare claims over purchase of Daughters of Charity Health System

DePuy Synthes announces acquisition of Olive Medical

Pfenex, Hospira sign agreement to develop and commercialize LUCENTIS biosimilar

Bayer materials withstand demanding conditions and meet requirements for innovative medical devices MD&M West

Isis receives $5 million from Biogen Idec to develop drugs for neurological disorders

PBI announces receipt of first purchase order for new Barozyme HT48 High-throughput System

Quest Diagnostics, Myriad Genetics reach agreement to end BRCA gene-patent litigation

Roche announces acquisition of Signature Diagnostics

Blyth's Silver Star Brands business unit acquires Native Remedies assets

Xenics and VUmc collaborate in thermography project for clinical research

Gilead Sciences, Mobiquity make significant healthcare investment in London

Lintec to commercialize carbon nanotubes developed at UTD

Trovagene to sell underwritten public offering of common stock

Marken launches new marketing campaign to solidify its place as industry's only Clinical Logistics Organization

Asterias Biotherapeutics prices underwritten public offering of common stock at $3.90 per share

G1 Therapeutics receives $33 million in Series B funding to develop effective treatments for cancer

Alexian Brothers Health System acquires primary care medical group in suburban Chicago

How microRNA is transforming science: From discovery to diagnostics

Advancing benzodiazepine detection

The Surgeon-Scientist Pioneering Regenerative Engineering

Latest News